Image courtesy of Planmed OY
June 25, 2015 - The U.S. Food and Drug Administration (FDA) issued an approval letter in may for the Planmed Verity CBCT (cone beam computed tomography) scanner's MaxScan maxillofacial imaging option. Planmed Verity is designed for imaging of anatomies within upper and lower extremities, as well as the maxillofacial region. The system utilizes CBCT technology with a flat panel detector, which provides high-resolution volumetric images. It is a compact, stand-alone unit from which all stages of the imaging process can be performed. Planmed Verity's MaxScan imaging option enables flexible CBCT imaging of the regions encompassing the jaw and face.
Planmed Verity has been specially designed to find subtle extremity fractures, the type most commonly missed by 2-D radiographs, within the first clinic visit. The CBCT scanner's MaxScan imaging option is a unique and cost-effective solution for evaluating maxillofacial fractures. It enables imaging of the jaw, teeth, sinuses, temporomandibular joints (TMJ), orbits, and airways - all at a low patient dose.
As a modern maxillofacial scanner, Planmed Verity has been designed with patient comfort in mind. The CBCT scanner includes an adjustable, soft-surfaced gantry and dedicated positioning tray, allowing for optimized patient comfort. The motorized gantry with adjustable height and tilt enables flexible positioning when imaging extremities or the maxillofacial area. A highly convenient sitting position along with an open gantry reduces patient anxiety, while lean-in positioning makes maxillofacial imaging a fast, more agreeable procedure.
For more information: www.planmed.com
April 16, 2024 
